News and Events 2018-02-27T10:49:24+00:00


RareCyte Completes $30M Private Financing for Commercial Expansion of Rare Cell Detection Technology for Liquid Biopsies

Seattle, WA, August 24, 2017 – RareCyte, Inc., a global rare cell detection and liquid biopsy company will use the funding to advance its commercial sales efforts and build companion diagnostics (CDx) programs with strategic partners. The company will also expand its regulatory infrastructure and research and development efforts. The $30M investment was led by 5AM Ventures with participation from existing investors Telegraph Hill Partners (THP), founder Ron Seubert and other investors. Read more


American Association for Cancer Research
April 14-18, 2018
Chicago, IL
Booth No. 3252

American Society for Clinical Oncology
June 1-5, 2018
Chicago, IL
Booth No. 18080